SORBINIL RETINOPATHY TRIAL

Project Details

Description

Oral sorbinil, an aldose reductase inhibitor, was administered in a
double-masked randomized trial to diabetics with no or minimal diabetic
retinopathy. This was done to evaluate the effects of sorbinil on the
development of diabetic retinopathy and to continue investigating the
safety and toleration of sorbinil. The study is being conducted
simultaneously in 10 research centers in the United States.
StatusNot started

ASJC

  • Ophthalmology
  • Pharmacology

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.